DISPERSYN GERRIT (Chief Development Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/3/2018ACC: 0001209191-18-045455
Officer· Chief Development Officer
Since Aug 2018
+32K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
32K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16K
Price / share
—
Trade value
—
% of position
4571.4%
8/1/2018
350.00→16.35K
Total
Net shares
+16K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2018 | A · Award | +16K | — | — | 4571.4% | 350.00 | 16.35K |
| Total | +16K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common stock
16K shares
Shares
+16K
Strike price
1.79
Held after
16K
Exercisable
—
8/1/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common stock16K shares | 8/1/2018 | A · Award | +16K | 1.79 | — | 16K |